AERIE PHARMACEUTICALS INC (AERI)
US00771V1089 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -36.55M | -74.81M | -183.10M | -199.58M | -232.57M | |||
| Depreciation Amortization | 6.43M | 6.40M | 6.37M | 5.14M | 2.44M | |||
| Change In Working Capital | 5.69M | -92.56M | 44.89M | -23.96M | 13.39M | |||
| Interest Paid | N/A | 4.74M | 5.03M | 6.50M | 1.77M | |||
| Taxes Paid | N/A | 0.00 | 4.99M | N/A | 0.00 | |||
| Other non cash items | 31.61M | 61.82M | 67.16M | 67.97M | 64.16M | |||
| OPERATING CASH FLOW | 7.17M | -99.15M | -64.69M | -150.43M | -152.58M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.53M | -3.29M | -3.10M | -9.96M | -31.31M | |||
| Other Investing Activity | -13.78M | -14.91M | 76.28M | -173.29M | 52.10M | |||
| INVESTING CASH FLOW | -18.30M | -18.20M | 73.18M | -183.25M | 20.79M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | 308.35M | N/A | |||
| Stock Issued/Repurchased | 3.38M | 2.97M | 0.00 | 760.00K | 135.97M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | 0.00 | -860.00K | -34.31M | 1.06M | |||
| FINANCING CASH FLOW | 3.38M | 2.97M | -860.00K | 274.80M | 137.04M | |||
| CHANGE IN CASH | -7.75M | -114.38M | 7.63M | -58.88M | 5.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 7.17M | -99.15M | -64.69M | -150.43M | -152.58M | |||
| Capital Expenditure | -4.53M | -3.29M | -3.10M | -9.96M | -31.31M | |||
| FREE CASH FLOW | 2.64M | -102.44M | -67.79M | -160.39M | -183.89M | |||
All data in USD